ABCL
Abcellera Biologics Inc
14.80$
+6.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.7% | 87.1% | 11.6% | 392.0% | 13.7% | 81.2% | 336.4% | 38.4% | |
| 100.0% | 100.0% | 88.4% | 100.0% | 86.3% | 100.0% | 100.0% | 61.6% | |
| 65.7% | 87.1% | 12.6% | 534.5% | 22.2% | 462.0% | 580.1% | 248.7% | |
| 24.4% | 23.7% | 5.1% | 23.7% | 11.4% | 160.4% | 252.2% | 110.8% | |
| 108.5% | 135.5% | 21.4% | 120.2% | 41.7% | 723.8% | 1,191.7% | 350.6% | |
| -8.5% | -35.5% | 66.9% | -35.5% | 44.6% | -623.8% | -1,091.7% | -289.0% | |
| 2.4% | 1.8% | 2.8% | 1.8% | 0.8% | – | – | – | |
| 3.5% | -19.0% | 67.7% | -19.0% | 49.3% | -457.7% | -695.0% | -236.4% | |
| 14.4% | 1.8% | 16.7% | 565.7% | 16.6% | -72.7% | -130.2% | -41.5% | |
| 3.5% | -19.0% | 51.0% | -19.0% | 32.7% | -385.0% | -564.8% | -194.9% | |
| 16.3% | -1.3% | 72.7% | -1.3% | 53.6% | -505.3% | -708.0% | -198.0% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.